OTTILONIO BROMURO-DIAZEPAM VERSUS PROPANTELINA-BROMAZEPAM NEL TRATTAMENTO DELLA SINDROME DA INTESTINO IRRITABILE

TRIAL MULTICENTRICO RANDOMIZZATO CONTROLLATO IN DOPPIO CIECO

Translated title of the contribution: Octilonium bromide-diazepam versus propantheline bromide-bromazepam in the treatment of irritable bowel-syndrome: A multicenter, randomized, controlled, double-blind trial

N. Dioguardi, R. De Franchis, D. Agape, F. Antoniozzi, E. Ballarin, A. Ferrara, A. Ferrari, L. Forzenigo, G. Minoli, A. Prada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A multi-center, double-blind, randomized controlled trial has been carried out to compare the efficacy of two preparations of similar pharmacologic properties largely used in the symptomatic treatment of the Irritable Bowel Syndrome. The two preparations used were: (A) the association of propantheline bromide 15 mg plus bromazepam, 1.5 mg, and (B) that of octilonium bromide 20 mg plus diazepam 2 mg. Each preparation was given t.i.d. for 30 days. Thirty-four patients were randomly assigned to receive preparation A, and 31 to preparation B. The following somatic signs and symptoms were analyzed in all patients: abdominal discomfort, alterations in bowel habits (constipation and/or diarrhea), bloating, flatulence, borborygmi, nausea and/or vomiting, indigestion, epigastric pain, heartburn. In addition, patients performed tests for the self-assessment of their psychological status, in order to define their emotional profile and its changes in relation to the drug treatment. All patients underwent clinic visits at time 0, and at 15 and 30 days thereafter (i.e. at mid-point and at the end of the study). During visits, the signs and symptoms were scored on previously designed sheets, and the self assessment psychological tests were conducted. Patients compliance was considered of paramount importance in assessing the efficacy of the two preparations being compared, especially in view of the type of patients studied, who are often noncompliant or poorly compliant to long-term treatment. From this point of view, patients on preparation A showed an excellent compliance to treatment. 91.2% of the patients in this group completed the period of treatment, as compared with 77.4% of the patients on preparation B. Every time a different response between the two treatment groups was observed, both for somatic and for psychological symptoms, patients on preparation A fared better than those on preparation B. In conclusion, the association propantheline bromide-bromazepam is at least as effective as that octilonium-diazepam for the treatment of patients with IBS. To show the possible superiority of the former above the latter in a statistically significant manner, one would need a sample size far larger than that of the present study.

Original languageItalian
Pages (from-to)97-104
Number of pages8
JournalTerapia Moderna
Volume5
Issue number4
Publication statusPublished - 1991

Fingerprint

Propantheline
Bromazepam
Irritable Bowel Syndrome
Diazepam
Bromides
Therapeutics
Signs and Symptoms
Psychology
Flatulence
Psychological Tests
Heartburn
Dyspepsia
Constipation
Patient Compliance
Ambulatory Care
Sample Size
Nausea
Habits
Vomiting
Diarrhea

ASJC Scopus subject areas

  • Medicine(all)

Cite this

OTTILONIO BROMURO-DIAZEPAM VERSUS PROPANTELINA-BROMAZEPAM NEL TRATTAMENTO DELLA SINDROME DA INTESTINO IRRITABILE : TRIAL MULTICENTRICO RANDOMIZZATO CONTROLLATO IN DOPPIO CIECO. / Dioguardi, N.; De Franchis, R.; Agape, D.; Antoniozzi, F.; Ballarin, E.; Ferrara, A.; Ferrari, A.; Forzenigo, L.; Minoli, G.; Prada, A.

In: Terapia Moderna, Vol. 5, No. 4, 1991, p. 97-104.

Research output: Contribution to journalArticle

Dioguardi, N. ; De Franchis, R. ; Agape, D. ; Antoniozzi, F. ; Ballarin, E. ; Ferrara, A. ; Ferrari, A. ; Forzenigo, L. ; Minoli, G. ; Prada, A. / OTTILONIO BROMURO-DIAZEPAM VERSUS PROPANTELINA-BROMAZEPAM NEL TRATTAMENTO DELLA SINDROME DA INTESTINO IRRITABILE : TRIAL MULTICENTRICO RANDOMIZZATO CONTROLLATO IN DOPPIO CIECO. In: Terapia Moderna. 1991 ; Vol. 5, No. 4. pp. 97-104.
@article{a3f5e604f8dc43b1945b86e3ad434022,
title = "OTTILONIO BROMURO-DIAZEPAM VERSUS PROPANTELINA-BROMAZEPAM NEL TRATTAMENTO DELLA SINDROME DA INTESTINO IRRITABILE: TRIAL MULTICENTRICO RANDOMIZZATO CONTROLLATO IN DOPPIO CIECO",
abstract = "A multi-center, double-blind, randomized controlled trial has been carried out to compare the efficacy of two preparations of similar pharmacologic properties largely used in the symptomatic treatment of the Irritable Bowel Syndrome. The two preparations used were: (A) the association of propantheline bromide 15 mg plus bromazepam, 1.5 mg, and (B) that of octilonium bromide 20 mg plus diazepam 2 mg. Each preparation was given t.i.d. for 30 days. Thirty-four patients were randomly assigned to receive preparation A, and 31 to preparation B. The following somatic signs and symptoms were analyzed in all patients: abdominal discomfort, alterations in bowel habits (constipation and/or diarrhea), bloating, flatulence, borborygmi, nausea and/or vomiting, indigestion, epigastric pain, heartburn. In addition, patients performed tests for the self-assessment of their psychological status, in order to define their emotional profile and its changes in relation to the drug treatment. All patients underwent clinic visits at time 0, and at 15 and 30 days thereafter (i.e. at mid-point and at the end of the study). During visits, the signs and symptoms were scored on previously designed sheets, and the self assessment psychological tests were conducted. Patients compliance was considered of paramount importance in assessing the efficacy of the two preparations being compared, especially in view of the type of patients studied, who are often noncompliant or poorly compliant to long-term treatment. From this point of view, patients on preparation A showed an excellent compliance to treatment. 91.2{\%} of the patients in this group completed the period of treatment, as compared with 77.4{\%} of the patients on preparation B. Every time a different response between the two treatment groups was observed, both for somatic and for psychological symptoms, patients on preparation A fared better than those on preparation B. In conclusion, the association propantheline bromide-bromazepam is at least as effective as that octilonium-diazepam for the treatment of patients with IBS. To show the possible superiority of the former above the latter in a statistically significant manner, one would need a sample size far larger than that of the present study.",
author = "N. Dioguardi and {De Franchis}, R. and D. Agape and F. Antoniozzi and E. Ballarin and A. Ferrara and A. Ferrari and L. Forzenigo and G. Minoli and A. Prada",
year = "1991",
language = "Italian",
volume = "5",
pages = "97--104",
journal = "Terapia Moderna",
issn = "0040-3695",
number = "4",

}

TY - JOUR

T1 - OTTILONIO BROMURO-DIAZEPAM VERSUS PROPANTELINA-BROMAZEPAM NEL TRATTAMENTO DELLA SINDROME DA INTESTINO IRRITABILE

T2 - TRIAL MULTICENTRICO RANDOMIZZATO CONTROLLATO IN DOPPIO CIECO

AU - Dioguardi, N.

AU - De Franchis, R.

AU - Agape, D.

AU - Antoniozzi, F.

AU - Ballarin, E.

AU - Ferrara, A.

AU - Ferrari, A.

AU - Forzenigo, L.

AU - Minoli, G.

AU - Prada, A.

PY - 1991

Y1 - 1991

N2 - A multi-center, double-blind, randomized controlled trial has been carried out to compare the efficacy of two preparations of similar pharmacologic properties largely used in the symptomatic treatment of the Irritable Bowel Syndrome. The two preparations used were: (A) the association of propantheline bromide 15 mg plus bromazepam, 1.5 mg, and (B) that of octilonium bromide 20 mg plus diazepam 2 mg. Each preparation was given t.i.d. for 30 days. Thirty-four patients were randomly assigned to receive preparation A, and 31 to preparation B. The following somatic signs and symptoms were analyzed in all patients: abdominal discomfort, alterations in bowel habits (constipation and/or diarrhea), bloating, flatulence, borborygmi, nausea and/or vomiting, indigestion, epigastric pain, heartburn. In addition, patients performed tests for the self-assessment of their psychological status, in order to define their emotional profile and its changes in relation to the drug treatment. All patients underwent clinic visits at time 0, and at 15 and 30 days thereafter (i.e. at mid-point and at the end of the study). During visits, the signs and symptoms were scored on previously designed sheets, and the self assessment psychological tests were conducted. Patients compliance was considered of paramount importance in assessing the efficacy of the two preparations being compared, especially in view of the type of patients studied, who are often noncompliant or poorly compliant to long-term treatment. From this point of view, patients on preparation A showed an excellent compliance to treatment. 91.2% of the patients in this group completed the period of treatment, as compared with 77.4% of the patients on preparation B. Every time a different response between the two treatment groups was observed, both for somatic and for psychological symptoms, patients on preparation A fared better than those on preparation B. In conclusion, the association propantheline bromide-bromazepam is at least as effective as that octilonium-diazepam for the treatment of patients with IBS. To show the possible superiority of the former above the latter in a statistically significant manner, one would need a sample size far larger than that of the present study.

AB - A multi-center, double-blind, randomized controlled trial has been carried out to compare the efficacy of two preparations of similar pharmacologic properties largely used in the symptomatic treatment of the Irritable Bowel Syndrome. The two preparations used were: (A) the association of propantheline bromide 15 mg plus bromazepam, 1.5 mg, and (B) that of octilonium bromide 20 mg plus diazepam 2 mg. Each preparation was given t.i.d. for 30 days. Thirty-four patients were randomly assigned to receive preparation A, and 31 to preparation B. The following somatic signs and symptoms were analyzed in all patients: abdominal discomfort, alterations in bowel habits (constipation and/or diarrhea), bloating, flatulence, borborygmi, nausea and/or vomiting, indigestion, epigastric pain, heartburn. In addition, patients performed tests for the self-assessment of their psychological status, in order to define their emotional profile and its changes in relation to the drug treatment. All patients underwent clinic visits at time 0, and at 15 and 30 days thereafter (i.e. at mid-point and at the end of the study). During visits, the signs and symptoms were scored on previously designed sheets, and the self assessment psychological tests were conducted. Patients compliance was considered of paramount importance in assessing the efficacy of the two preparations being compared, especially in view of the type of patients studied, who are often noncompliant or poorly compliant to long-term treatment. From this point of view, patients on preparation A showed an excellent compliance to treatment. 91.2% of the patients in this group completed the period of treatment, as compared with 77.4% of the patients on preparation B. Every time a different response between the two treatment groups was observed, both for somatic and for psychological symptoms, patients on preparation A fared better than those on preparation B. In conclusion, the association propantheline bromide-bromazepam is at least as effective as that octilonium-diazepam for the treatment of patients with IBS. To show the possible superiority of the former above the latter in a statistically significant manner, one would need a sample size far larger than that of the present study.

UR - http://www.scopus.com/inward/record.url?scp=0026046268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026046268&partnerID=8YFLogxK

M3 - Articolo

VL - 5

SP - 97

EP - 104

JO - Terapia Moderna

JF - Terapia Moderna

SN - 0040-3695

IS - 4

ER -